tirzepatide weight loss trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Impact of Body Mass Index,

National Post Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary

The 30-Day GHK-Cu Injection Cycle: Loading Phase, Maintenance Phase, and What to Expect The GHK-Cu dosage protocol is divided into two 15-day phases within a 30-day active window, followed by a 30-day rest period before the next cycle begins

Doctors need the tools to manage patients effectively, distinguish fact from speculation, and communicate risks without causing unnecessary fear

K.HeckmannN

And today we're going to talk about tariffs

New guidelines have expanded the use of B12 injections, particularly in the elderly with cognitive decline, bringing to light an essential approach to well-being in older age